M. Kohout et al., COOL PERFUSION SOLUTIONS FOR SKIN FLAPS - A NEW MIXTURE OF PHARMACOLOGICAL AGENTS WHICH IMPROVES SKIN FLAP VIABILITY, British Journal of Plastic Surgery, 48(3), 1995, pp. 132-144
This study tested the hypotheses that perfusion of cooled skin flaps w
ith established organ preservation solutions improves their viability
and that this improvement can be further enhanced by pharmacological m
anipulation. Rabbit epigastric skin flaps were perfused with different
solutions before explantation and stored at 8 degrees C for 6 days. I
n the first part of the experiment, flap viability was assessed 7 days
after reperfusion of the flap via microvascular anastomoses. The diff
erent solutions were heparinised blood, University of Wisconsin soluti
on, two of its modifications, EuroCollins solution and a pharmacologic
al mixture containing phosphoenolpyruvate, desferrioxamine, nitrendipi
ne, dextran 70 and a platelet-aggregating factor receptor antagonist (
WEB 2170). In the second part, biochemical parameters of skin were mea
sured at various reperfusion times. Adenosine triphosphate (ATP), redu
ced glutathione (GSH), myeloperoxidase (MPO) and tissue water were ass
ayed at 0, 1, and 24 h after reperfusion. In addition, plasma thrombox
ane (TXB(2)) was measured at 0, 30 and 60 minutes after reperfusion. T
he viability of flaps perfused with the mixture (81%) was significantl
y higher than that of any of the other groups (39% for controls, 38% f
or EuroCollins, 13% for UW solution, 27% and 31% for its modifications
). ATP levels after reperfusion were higher in the mixture group than
in UW-perfused group. GSH levels in the mixture group were also higher
than in the UW group, indicating higher level of protection against o
xidative stress during reperfusion. There were no differences in MPO l
evels. Thromboxane levels associated with UW-perfused flaps were signi
ficantly higher than those associated with any other perfusion solutio
n. In conclusion, perfusion of a mixture of pharmacological agents tar
geting specific aspects of ischaemia/reperfusion injury improved the v
iability of skin flaps stored in the cold for 6 days, whereas standard
organ preservation solutions failed to affect significantly skin flap
survival.